Systems pharmacology dissection of action mechanisms for herbs in osteoporosis treatment
- Author:
Ying HUAI
1
;
Wen-juan ZHANG
1
;
Wei WANG
1
;
Kai DANG
1
;
Shan-feng JIANG
1
;
Zhi-ping MIAO
1
;
Yu LI
1
;
Ai-rong QIAN
1
;
Ying HUAI
2
;
Wen-juan ZHANG
2
;
Wei WANG
2
;
Kai DANG
2
;
Shan-feng JIANG
2
;
Zhi-ping MIAO
2
;
Yu LI
2
;
Ai-rong QIAN
2
;
Ying HUAI
3
;
Wen-juan ZHANG
3
;
Wei WANG
3
;
Kai DANG
3
;
Shan-feng JIANG
3
;
Zhi-ping MIAO
3
;
Yu LI
3
;
Ai-rong QIAN
3
;
Dan-ming LI
4
;
Meng LI
5
;
Qiang HAO
5
Author Information
- Publication Type:Journal Article
- Keywords: asperosaponin VI; betulinic acid; calycosin; drug discovery; hederagenin; luteolin; osteoporosis; systems pharmacology; traditional Chinese medicine
- From: Chinese Herbal Medicines 2021;13(3):313-331
- CountryChina
- Language:Chinese
- Abstract: Objective: Osteoporosis has become the biggest cause of non-fatal health issue. Currently, the limitations of traditional anti-osteoporosis drugs such as long-term ill-effects and drug resistance, have raised concerns toward complementary and alternative therapies, particularly herbal medicines and their natural active compounds. Thus, this study aimed to provide an integrative analysis of active chemicals, drug targets and interacting pathways of the herbs for osteoporosis treatment. Methods: Here, we introduced a systematic pharmacology model, combining the absorption, distribution, metabolism, and excretion (ADME) screening model, drug targeting and network pharmacology, to probe into the therapeutic mechanisms of herbs in osteoporosis. Results: We obtained 86 natural compounds with favorable pharmacokinetic profiles and their 58 targets from seven osteoporosis-related herbs. Network analysis revealed that they probably synergistically work through multiple mechanisms, such as suppressing inflammatory response, maintaining bone metabolism or improving organism immunity, to benefit patients with osteoporosis. Furthermore, experimental results showed that all the five compounds (calycosin, asperosaponin VI, hederagenin, betulinic acid and luteolin) enhanced osteoblast proliferation and differentiation in vitro, which corroborated the validity of this system pharmacology approach. Notably, gentisin and aureusidin among the identified compounds were first predicted to be associated with osteoporosis. Conclusion: Herbs and their natural compounds, being characterized as the classical combination therapies, might be engaged in multiple mechanisms to coordinately improve the osteoporosis symptoms. This work may contribute to offer novel strategies and clues for the therapy and drug discovery of osteoporosis and other complex diseases.
